1 sublineages at low residual titers, was uploaded to MedRxiv, and a preprint describing a novel approach for predicting mAb activity was uploaded to BioRxiv. Published first on TheFly – the ultimate ...
In the ongoing Phase Ⅰ trial, 70 older adult & elderly subjects were enrolled and received either Clover's SCB-1019, GSK's AREXVY or saline placebo. Preliminary results for immunogenicity and safety ...
Researchers assessed the safety of obeldesivir and its effectiveness against COVID-19-related hospitalization and all-cause mortality in high-risk adult patients.